Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Gerrits: Skin Autofluorescence. (0.06 sec) 

[PDF] Personalized Medicine for Diabetes


DC Klonoff - Journal of Diabetes Science and Technology, 2008 - journalofdst.org
Abbreviations: (KCNJ11) potassium inwardly rectifying channel, subfamily J,
member 11, (OCT1) organic cation transporter 1, (PMFD) personalized medicine for
diabetes ... Keywords: diabetes, genetics, genomics, pharmacogenomics. ...
Cited by 1 - Related articles - View as HTML

Skin autofluorescence for the risk assessment of chronic complications in diabetes: a broad …

- diagnoptics.com [PDF] 
M Koetsier, H Lutgers, AJ Smit, TP Links, R … - Optics Express, 2009 - opticsinfobase.org
Skin autofluorescence (AF) is becoming an accepted clinical method for assessing
the risk of chronic complications in diabetes mellitus (DM). In this study, the
role of the excitation wavelength in the recognition of increased risk of ...
Cited by 1 - Related articles - All 6 versions

The clinical relevance of assessing advanced glycation endproducts accumulation in …


R Meerwaldt, T Links, C Zeebregts, R Tio, JL … - Cardiovascular Diabetology, 2008 - cardiab.com
Cardiovascular disease is the major cause of morbidity and mortality associated
with diabetes. There is increasing evidence that advanced glycation endproducts
(AGEs) play a pivotal role in atherosclerosis, in particular in diabetes. ...
Cited by 1 - Related articles - Cached - All 8 versions

[PDF] Skin Advanced Glycation End Product Accumulation Is Poorly Reflected by Glycemic Control …


EG Gerrits, HL Lutgers, N Kleefstra, KH … - Journal of Diabetes Science and Technology, 2008 - journalofdst.org
Esther G. Gerrits, MD,1 Helen L. Lutgers, MD,2 Nanne Kleefstra, MD,3 Klaas H.
Groenier, Ph.D.,4 Andries J. Smit, MD, Ph.D.,2 Rijk OB Gans, MD, Ph.D.,5 and
Henk JG Bilo, MD, Ph.D.6 ... Author Affiliations: 1Department of Internal ...
Related articles - View as HTML - All 3 versions

AGEs, autofluorescence and renal function

- oxfordjournals.org
EG Gerrits, AJ Smit, HJG Bilo - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA
Accelerated formation and accumulation of AGEs occur under circumstances of
hyperglycaemic or oxidative stress in age-related and chronic diseases like
diabetes mellitus, chronic renal failure, neurodegenerative diseases, ...
Related articles - All 6 versions

24 Glycation End Products


L Declercq, H Corstjens, D Maes - Handbook of Cosmetic Science and Technology, 2009 - books.google.com
24 Glycation End Products Lieve Declercq and Hugo Corstjens Biological Research
Department Europe, Este'e Lauder Companies, Oevel, Belgium Daniel Maes Research
and Development, Este'e Lauder Companies, Melville, New York, USA ...
Related articles

Accumulation of Advanced Glycation End Products and Chronic Complications in ESRD …


R Meerwaldt, CJ Zeebregts, G Navis, JL … - American Journal of Kidney Diseases, 2009 - Elsevier
Cardiovascular and connective tissue disorders are very common in patients with
end-stage renal disease (ESRD), and the accumulation of advanced glycation end
products (AGEs) is significantly increased in these patients. Accumulation ...
Related articles - All 3 versions

[PDF] ADVANCED GLYCATION END PRODUCTS IN RENAL FAILURE: AN OVERVIEW


MJ Noordzij, JD Lefrandt, AJ Smit - Journal of Renal Care, 2008 - diagnoptics.com
SUMMARY The article aims to present an overview of the existing knowledge on
advanced glycation end products (AGE). They are moieties that bind to proteins,
but also lipids and nuclear acids. AGE are formed during glycation and ...
Related articles - View as HTML - All 4 versions

Regarding “Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal …


R Meerwaldt, A Blomme, W Fritschy, CJ … - Journal of Vascular Surgery, 2008 - Elsevier
We recently analyzed our results for endoluminal therapy with expanded
polytetrafluorethylene (ePTFE)-covered endografts for superficial femoral artery
(SFA) occlusive disease (mix of claudicants and critical limb ischemia). ...
Related articles - All 17 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google